Delivery system for therapy comprising hollow seeds, and the method of use thereof
OwnerAnatoly Dritschilo, Mira Jung +1inventors
InventorsAnatoly Dritschilo, Mira Jung, Manny R. Subramanian
Life of this patent
Estimating the term…
Abstract
Hollow metal and polymeric containers (or seeds) are provided having a therapeutic agent encapsulated therein, e.g., a nucleic acid or cytokine, that diffuses out of the seeds via one or more holes disposed therein and is thereby delivered to target sites, e.g., tumor cells. These hollow seeds can be precisely delivered to garget cites, e.g., within a tumor, preferably by use of stereotactic guidance, ultrasound, CT or MRI.
Claims20
(canceled)
The method of claim 18, wherein said container has a tubular configuration that is open at one or both ends.
The method of claim 18, wherein said hollow container is constructed of a metal or metal alloy comprising at least one metal or metal alloy selected from the group consisting of platinum, stainless steel, titanium, silver, and gold.
(canceled)
(canceled)
(canceled)
The method of claim 18, wherein precise placement of said therapeutic agent encapsulating container to said target site is visually confirmed by a method selected from the group consisting of stereotactic-guidance, CT, ultrasound, and MRI.
The method of claim 18, wherein said therapeutic agent encapsulating container are implanted at one or more sites in a tumor.
The method of claim 18, which is used to target a therapeutic agent to sites comprising cancerous lesions, infection or inflammation.
The method of claim 18, wherein said hollow container contains within the hollow interior a nucleic acid sequence.
The method of claim 18, wherein the therapeutic agent is a cytokine.
The method of claim 18, wherein the therapeutic agent is a radiosensitizing gene.
A method for delivering a therapeutic agent to a targeted site in a living subject by interstitial drug delivery, comprising the following steps:
- i) producing a hollow container sized and adapted for insertion into a tissue or organ in vivo, and having encapsulated in the hollow interior thereof at least one therapeutic agent capable of diffusing out of said container through one or more holes therein;
- ii) freezing said container and the therapeutic agent therein to a temperature of about −70° C.
- iii) maintaining said container and the therapeutic agent therein in a frozen state from said freezing until insertion into a living subject;
- iv) inserting one or more of said therapeutic agent containing containers to within about 1 millimeter of a targeted site within tissue or an organ in said living subject;
- and
- v) permitting the therapeutic agent to diffuse from said container at said targeted site.
Dependencies are inferred from the claim text.